Trials / Completed
CompletedNCT00495898
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
A German Multicenter, Randomized, Controlled, Open-Label Study of the Cypher Sirolimus-Eluting Stent in the Treatment of Diabetic Patients With De Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the safety and effectiveness of the CYPHER sirolimus-eluting stent in maintaining minimum lumen diameter in de novo native coronary artery lesions as compared to the uncoated Bx VELOCITY balloon-expandable stent in patients with manifest diabetes mellitus. Both stents are mounted on the Raptorâ Rapid Exchange Stent Delivery System.
Detailed description
This is a multicenter (19 sites), prospective, 2 arm randomized study designed to assess the safety and effectiveness of the CYPHER sirolimus-eluting stent as compared to the uncoated Bx VELOCITY balloon-expandable stent in patients with manifest diabetes mellitus. Patients with de novo native coronary artery lesions \<= 42 mm in length and \>=2.5mm and \<=3.5mm in diameter (by visual estimate) will be included in the study. A total of 190 patients will be entered and randomly allocated to the CYPHERTM sirolimus-eluting stent or the uncoated Bx VELOCITY balloon-expandable stent at a 1:1 ratio. Patients will be followed for 12 months post-procedure, with all patients having a repeat angiography at 8 months (± 1 month). It is anticipated the total duration of the study will be 18 months: 6 months to complete patient enrollment and 12 months for follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CYPHER sirolimus-eluting stent | drug-eluting stent |
| DEVICE | uncoated Bx VELOCITY balloon-expandable stent | bare metal stent |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2005-05-01
- Completion
- 2009-11-01
- First posted
- 2007-07-03
- Last updated
- 2009-12-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00495898. Inclusion in this directory is not an endorsement.